Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

FDA Approvals: Dr Reddy's Receives FDA Nod For Acid Reflux Drug Omeprazole & Sodium Bicarbonate - Dr. Reddy\'s Laboratories

Dr. Reddy's Laboratories

Uploaded: 2021

Dr. Reddy's Sets Sbti-Approved Net Zero Target For FY2045

12 Dec 2025

// EXPRESSPHARMA

Coya Therapeutics Begins COYA 302 Dosing in ALSTARS Trial

09 Dec 2025

// PRESS RELEASE

Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug

08 Dec 2025

// PRESS RELEASE

DATA COMPILATION
#PharmaFlow

DRL VB RM

Contact Supplier

CPhI Milan

Booth #5D18

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

https://www.pharmacompass.com/video-pharmareel/dr-reddys-laboratories/leading-supplier-of-apis-for-40-years

Xls

CATEGORY PAGE

Dr. Reddy's Laboratories

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2025, Corporate Presentation, API Product List 2025, Products Under Development 2025, FDF Product List 2024, GMP Certificate 2024

Product List 2025
Corporate Presentation
API Product List 2025
Products Under Development 2025
FDF Product List 2024
GMP Certificate 2024

VIDEO(s)

Leading Supplier of APIs for 40+ Years, Your Partner for High-Quality & Cost-effective APIs, Dr. Reddy's - About Us

Leading Supplier of APIs for 40+ Years
Your Partner for High-Quality & Cost-effective APIs
Dr. Reddy's - About Us

DIGITAL CONTENT

2 Vlog #PharmaReel, 9 Corporate Content #SupplierSpotlight, 11 Data Compilation #PharmaFlow, 1083 News #PharmaBuzz

2 Vlog #PharmaReel
9 Corporate Content #SupplierSpotlight
11 Data Compilation #PharmaFlow
1083 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

280 All APIs, 161 USDMF, 41 CEP/COS, 34 JDMF, 114 EU WC, 150 KDMF, 114 NDC API, 151 Listed APIs

280 All APIs
161 USDMF
41 CEP/COS
34 JDMF
114 EU WC
150 KDMF
114 NDC API
151 Listed APIs

DEVELOPMENTS

394 Drugs in Development

394 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1304 FDF Dossiers, 588 FDA Orange Book, 75 Europe, 58 Canada, 208 Australia, 152 South Africa, 223 Listed Dossiers

1304 FDF Dossiers
588 FDA Orange Book
75 Europe
58 Canada
208 Australia
152 South Africa
223 Listed Dossiers

KEY PRODUCTS

Atorvastatin, Bempedoic Acid, Cabozantinib, Carfilzomib, Clopidogrel, Clopidogrel Besylate, Clopidogrel Hydrochloride, Dabigatran Etexilate Mesylate, Dapagliflozin, Dapagliflozin Propanediol Monohydrate, Empagliflozin, Enzalutamide, Eribulin, Gemcitabine, Ketorolac Trometamol, Levetiracetam, Lumateperone Tosylate, Lurasidone Hydrochloride, Mirabegron, Naproxen, Naproxen Sodium, Nilotinib, Nizatidine, Olaparib, Palbociclib, Perfluorohexyloctane, Pioglitazone, Pioglitazone Hydrochloride, Pregabalin, Rivaroxaban, Sacubitril-Valsartan, Sitagliptin Hydrochloride, Sitagliptin Malate, Sitagliptin Phosphate, Sumatriptan, Tucatinib, Vonoprazan Fumarate, Xanomeline

EXCIPIENTS

1 All Excipients, 1 USDMF

1 All Excipients
1 USDMF

INSPECTIONS & REGISTRATIONS

66 FDA, 37 EDQM, 18 GDUFA, 5 Third-Party Audit

66 FDA
37 EDQM
18 GDUFA
5 Third-Party Audit

PC100302

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!